Cardinal HealthCAHEarnings & Financial Report
Cardinal Health, Inc. is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products.
CAH Q2 2026 Key Financial Metrics
Revenue
$65.6B
Gross Profit
$2.4B
Operating Profit
$707.0M
Net Profit
$467.0M
Gross Margin
3.7%
Operating Margin
1.1%
Net Margin
0.7%
YoY Growth
19.6%
Financial Flow
Cardinal Health Q2 2026 Financial Summary
Cardinal Health reported revenue of $65.6B for Q2 2026, with a net profit of $467.0M (0.7% margin). Cost of goods sold was $63.2B, operating expenses totaled $1.7B.
Key Financial Metrics
| Total Revenue | $65.6B |
|---|---|
| Net Profit | $467.0M |
| Gross Margin | 3.7% |
| Operating Margin | 1.1% |
| Report Period | Q2 2026 |
Cardinal Health Annual Revenue by Year
Cardinal Health annual revenue history includes year-by-year totals (for example, 2025 revenue was $239.4B).
| Year | Annual Revenue |
|---|---|
| 2025 | $239.4B |
| 2024 | $217.4B |
| 2023 | $213.2B |
| 2022 | $190.7B |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $54.91B | $52.28B | $55.26B | $54.88B | $54.88B | $64.01B | $65.63B | $65.63B |
| YoY Growth | 8.8% | -4.5% | -3.8% | -0.1% | -0.1% | 22.4% | 18.8% | 19.6% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $45.12B | $43.06B | $47.00B | $49.87B | $53.12B | $55.23B | $58.08B | $58.08B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $-3.21B | $-3.28B | $-2.99B | $-2.95B | $-2.78B | $-2.88B | $-2.88B | $-2.88B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $2.08B | $-1.65B | $-400.0M | $2.92B | $1.53B | $973.0M | $686.0M |
Other Health Care Companies
COR
Cencora
Revenue
$85.9B
Net Profit
$559.6M
HSIC
Henry Schein
Revenue
$3.3B
Net Profit
$101.0M
MCK
McKesson Corporation
Revenue
$106.2B
Net Profit
$1.2B
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B
BAX
Baxter International
Revenue
$3.0B
Net Profit
$-1.1B
BDX
Becton Dickinson
Revenue
$5.3B
Net Profit
$382.0M